MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Miglustat

Miglustat 65mg capsules

No stability information

Stability notes for Miglustat 65mg capsules

There are no stability notes for this medicine.

Supplier

Opfolda 65mg capsules (Amicus Therapeutics UK Operations Ltd)

Miglustat 100mg capsules

Compatible

Stability notes for Miglustat 100mg capsules

No special precautions for storage.

Provenance

Compatibility information derived from Zavesca 100mg capsules (Janssen-Cilag Ltd).

Suppliers (6) of Miglustat 100mg capsules
Miglustat 100mg capsules (A A H Pharmaceuticals Ltd)
Miglustat 100mg capsules (Accord-UK Ltd)
Miglustat 100mg capsules (Flynn Pharma Ltd)
Miglustat 100mg capsules (Sovereign Medical Ltd)
Yargesa 100mg capsules (Piramal Critical Care Ltd)
Zavesca 100mg capsules (Janssen-Cilag Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.